Open Access
Subscription Access
Understanding Myocarditis and Drugs that Act on it
Abstract
Myocarditis is condition manifested by inflammation of the heart muscle, termed as the myocardium. This inflammation happens by many types of factors namely auto immune diseases, an exposure to certain toxins and infections. It is a serious condition that can result in heart failure without proper treatment. In treating myocarditis, many drugs play an important role in alleviating symptoms, decreasing inflammation and preserving heart function. Non steroidal anti_ inflammatimiry drugs such as ibuprofen are helpful in relieving pain and decreasing inflammation particularly in mild cases of myocarditis. Whatever it may be, caution may be taken because these drugs may show an adverse effects particularly on the gastro intestinal tract and kidneys. In cases where myocarditis is linked to an auto immune response, corticosteroids such as prednisone may be helpful. Cyclosporin may be used to modulate the immune response particularly in cases where the inflammation is due to an over active immune system attacking the heart tissue. If a viral infection is identified as the cause of myocarditis, anti viral drugs are generally useful. Myocarditis can result in heart failure and medications namely angiotensin _ converting enzyme ( ACE ) inhibitors, beta _ blockers and diuretics may be useful in treating heart function and fluid balance. In a very few cases, the risk of blood clot formation may enhance because of an impaired heart function. To prevent clot formation and lower the risk of problems, anticoagulants such as warfarin or direct oral anticoagulants (DOACs) may be administered. Emerging treatments include biological therapies that target specific pathways participated particularly in inflammation. Mono clonal antibodies and other biologics may play an important role in more targeted and personalized approach's to myocarditis treatment. Finally it is concluded that the management of myocardi6 involves a multifaceted approach, frequently requiring a combination of drugs to address inflammation, immune response and associated complications.
References
Caforio, A. L., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., ... & Elliott, P. M. (2013). Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal, 34(33), 2636-2648.
Mehta, J. J., Vindhyal, M. R., Boppana, V. S., & Farhat, A. (2018). Focal Myopericarditis Presenting as Acute ST-Elevation Myocardial Infarction. Kansas Journal of Medicine, 11(3), 83.
Jois, A., Zannino, D., Curtis, N., Cheung, M., Burgner, D. P., & Chen, K. Y. (2019). Arterial structure and function following viral myocarditis. Pediatric Cardiology, 40, 133-137.
Zeb, M., Sambu, N., Scott, P., & Curzen, N. (2011). Takotsubo cardiomyopathy: a diagnostic challenge. Postgraduate medical journal, 87(1023), 51-59.
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L., Cooper, L. T., Felix, S. B., ... & Van Linthout, S. (2021). Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology, 18(3), 169-193.
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L., Cooper, L. T., Felix, S. B., ... & Van Linthout, S. (2021). Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology, 18(3), 169-193.
Takeuchi, S., Kawada, J. I., Okuno, Y., Horiba, K., Suzuki, T., Torii, Y., ... & Ito, Y. (2018). Identification of potential pathogenic viruses in patients with acute myocarditis using next‐generation sequencing. Journal of Medical Virology, 90(12), 1814-1821.
Dionne, A., & Dahdah, N. (2018). Myocarditis and Kawasaki disease. International Journal of Rheumatic Diseases, 21(1), 45-49.
Chang, J. J., Lin, M. S., Chen, T. H., Chen, D. Y., Chen, S. W., Hsu, J. T., ... & Lin, Y. S. (2017). Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment-a nationwide cohort study. International journal of medical sciences, 14(12), 1241.10.
Mensah, G. A., Fuster, V., Murray, C. J., & Roth, G. A. (2023). Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American College of Cardiology, 82(25), 2350-2473.
Vos, T., Barber, R. M., Bell, B., Bertozzi Villa, A., Biryukov, S., Bolliger, I., ... & Brugha, T. S. (2015). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386, 743-800.12.
Patriki, D., Gresser, E., Manka, R., Emmert, M. Y., Lüscher, T. F., & Heidecker, B. (2018). Approximation of the incidence of myocarditis by systematic screening with cardiac magnetic resonance imaging. JACC: Heart Failure, 6(7), 573-579.
Blauwet, L. A., & Cooper, L. T. (2010). Myocarditis. Progress in cardiovascular diseases, 52(4), 274-288.
Bracamonte-Baran, W., & Čiháková, D. (2017). Cardiac autoimmunity: myocarditis. The Immunology of Cardiovascular Homeostasis and Pathology, 187-221.
WD, A. H. B. M. E. (1987). Factor SM Fallon JT Fenoglio JJ Jr Olsen EG Schoen FJ Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol, 1(3), 14.
Mason, J. W., O'connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., ... & Myocarditis Treatment Trial Investigators. (1995). A clinical trial of immunosuppressive therapy for myocarditis. New England Journal of Medicine, 333(5), 269-275.
Leong, K., Kane, J. M., & Joy, B. F. (2018). Acquired cardiac disease in the pediatric intensive care unit. Pediatric annals, 47(7), e280-e285.
Datta, T., & Solomon, A. J. (2018). Clozapine-induced myocarditis. Oxford Medical Case Reports, 2018(1), omx080.
Saricam, E., Saglam, Y., & Hazirolan, T. (2017). Clinical evaluation of myocardial involvement in acute myopericarditis in young adults. BMC Cardiovascular Disorders, 17(1), 1-6.
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., ... & Friedrich, M. G. (2018). Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. Journal of the American College of Cardiology, 72(24), 3158-3176.
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., ... & Virmani, R. (2007). The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation, 116(19), 2216-2233.
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., ... & Camici, P. G. (2020). Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circulation: Heart Failure, 13(11), e007405.
Patriki, D., Baltensperger, N., Berg, J., Cooper, L. T., Kissel, C. K., Kottwitz, J., ... & Heidecker, B. (2021). A prospective pilot study to identify a myocarditis cohort who may safely resume sports activities 3 months after diagnosis. Journal of cardiovascular translational research, 14, 670-673.
Abutaleb, A. R. A., McNally, E. M., Khan, S. S., Anderson, A. S., Carr, J. C., & Wilcox, J. E. (2018). Myocarditis in Duchenne muscular dystrophy after changing steroids. JAMA cardiology, 3(10), 1006-1010.
Maisch, B., & Alter, P. (2018). Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins. Herz, 43(5), 423.
Ammirati, E., Cipriani, M., Moro, C., Raineri, C., Pini, D., Sormani, P., ... & Registro Lombardo delle Miocarditi. (2018). Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation, 138(11), 1088-1099.
Kang, M., Chippa, V., & An, J. (2017). Viral myocarditis. Kang, M., Chippa, V., & An, J. (2017). Viral myocarditis.
Ammirati, E., Cipriani, M., Lilliu, M., Sormani, P., Varrenti, M., Raineri, C., ... & Frigerio, M. (2017). Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation, 136(6), 529-545.
Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., & Maseri, A. (2003). Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation, 107(6), 857-863.
Refbacks
- There are currently no refbacks.